Clinical Trials

ADVL1921: PHASE 1/2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE(REGISTERED)) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND/OR IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS

Link : https://www.clinicaltrials.gov/ct2/show/NCT03709680
Status : RECRUITING
Population : Ewing Sarcoma, Rhabdomyosarcoma, other Solid Tumors (2-20yrs)
Description : Palbociclib + chemo
PI : D. Morgernstern
Y. Samson
Centers Opened : SickKids
CHU Ste-Justine
Phase : II
IIST/Pharma : COG + Pharma